https://www.gosh.nhs.uk/news/gosh-voice-to-host-sibling-bowling-day-for-national-siblings-day/
GOSH Voice to host Sibling Bowling Day for National Siblings Day
2 Apr 2026, 11 a.m.
GOSH Voice will be hosting a sibling bowling day on 11 April 2026 to celebrate National Siblings Day on 10 April.
The bowling event is a fun chance to meet other siblings, who understand what it is like to have a brother or sister at GOSH.
It will be a day of activities, games, and bowling, and we will explore how we can make GOSH better for siblings. Travel, lunch, drinks and snack are all covered for the day.
The event is organised by GOSH Voice which is our vibrant coproduction community at GOSH. It is designed to bring together patients, siblings, parents, carers, and extended family to help shape the future of the hospital. It’s all about listening to lived experience, championing diverse voices, and co-creating meaningful change.
If you’re a sibling of a GOSH inpatient or outpatient and between aged seven to 21 years old, the GOSH Voice team would love to see you at the event.
Key details:
- Saturday 11 April.
- 10.30am to 4pm
- For GOSH brothers and sisters
If you have any questions, please email GOSHVoice@gosh.nhs.uk
Transport for London (TfL) strikes: May and June 2026
There are upcoming London Underground strikes planned which may affect your journey to GOSH.
Better understanding leukaemia for children with down syndrome
Researchers have mapped the evolution of a type of leukaemia that is exclusive to children with Down syndrome and may have identified an overarching weakness in the cancer's genetic makeup.
Surgeon who saved children’s sight surprised by patients, family and colleagues
Professor Chris Lloyd, consultant ophthalmic surgeon and paediatric ophthalmologist, was given a surprise to remember as a part of the BBC The One Show’s ‘One Big Thank You’.
Gentler treatment eliminates early deaths for children with relapsed leukaemia
A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.